Dubai: The Third International Conference of the Emirates Rare Diseases Society took place today in Dubai, bringing together a wide array of experts and stakeholders to delve into the role of artificial intelligence (AI) in diagnosing and treating rare diseases. The event was organized in collaboration with the Ministry of Health and Prevention, the Dubai Health Authority, and various universities and institutions both domestic and international, focusing on raising awareness, sharing experiences, and exploring collaboration opportunities to enhance care for individuals with rare diseases.
According to Emirates News Agency, Dr. Abdullah Al Khayyat, CEO of Al Jalila Hospital in Dubai, inaugurated the event, which was attended by notable figures including Mona Khalifa Hamad, Member of the Federal National Council, Dr. Younis Kazim, Advisor at Dubai Health, and Dr. Eman Taryam Al Shamsi, Chairman of the Conference and Member of the Medical Committee of the Emirates Rare Diseases Society. The conference attracted over 300 doctors, as well as children with rare diseases and their families.
In his opening speech, Dr. Al Khayyat highlighted the complexities and challenges posed by rare diseases, which often manifest in childhood and lead to severe disabilities and early mortality. He emphasized the importance of the conference in learning about the latest advancements in AI for diagnosis and treatment, and spreading awareness to complement the efforts of the Emirates Rare Diseases Society.
Dr. Iman Taryam Al Shamsi, President of the conference organized by Meeting Minds, outlined the conference's focus on the latest diagnostic and therapeutic methods through 28 specialized and interactive sessions. The scientific program aims to ensure a better quality of life for patients and their families by addressing their daily challenges and providing suitable solutions.
The final day of the conference will include a program dedicated to patients and their families, facilitating direct discussions with specialists about the difficulties they face. Dr. Al Shamsi emphasized the association's aim to provide moral and psychological support, raise awareness, and advocate for public health policies that support those affected by rare diseases across the UAE.
Nafisa Tawfiq, Chairman of the Board of Directors of the Emirates Rare Diseases Society and Chairman of the Organizing Committee of the Conference, highlighted the UAE's commitment to rare diseases under its wise leadership. The family program will focus on prevention through premarital examinations, government support for people of determination, advocacy, and chronic disease management during adolescence.
The conference also features an exhibition with 13 local and international companies showcasing the latest modern medicines, underscoring the event's significance as one of the UAE's premier annual conferences.